Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CASTLE BIOSCIENCES INC Director's Dealing 2021

Jul 28, 2021

32601_dirs_2021-07-28_d4fe60a0-2c26-4f74-8935-3ca316045b1c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-07-26

Reporting Person: BRADBURY DANIEL (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-07-26 Common Stock S 1600 $66.637 Disposed 284393 Indirect
2021-07-26 Common Stock S 900 $67.70 Disposed 283493 Indirect
2021-07-26 Common Stock S 1250 $66.728 Disposed 154031 Indirect
2021-07-26 Common Stock S 1250 $66.333 Disposed 154054 Indirect
2021-07-27 Common Stock S 1241 $62.802 Disposed 282252 Indirect
2021-07-27 Common Stock S 1059 $63.526 Disposed 281193 Indirect
2021-07-27 Common Stock S 200 $64.349 Disposed 280993 Indirect
2021-07-27 Common Stock S 1250 $63.076 Disposed 152781 Indirect
2021-07-27 Common Stock S 1250 $63.156 Disposed 152804 Indirect

Footnotes

F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted collectively by BioBrit, LLC (the "LLC"), The Annette E. Bradbury Irrevocable Descendants' Trust, and The Daniel M. Bradbury Irrevocable Descendants' Trust on May 26, 2021.

F2: This transaction was executed in multiple trades at prices ranging from $66.400 to $67.100, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.

F4: This transaction was executed in multiple trades at prices ranging from $67.430 to $68.255, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $66.210 to $67.040, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

F7: This transaction was executed in multiple trades at prices ranging from $66.210 to $66.500, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

F9: This transaction was executed in multiple trades at prices ranging from $62.110 to $63.100, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F10: This transaction was executed in multiple trades at prices ranging from $63.120 to $63.880, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F11: This transaction was executed in multiple trades at prices ranging from $64.280 to $64.480, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F12: This transaction was executed in multiple trades at prices ranging from $62.550 to $63.470, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F13: This transaction was executed in multiple trades at prices ranging from $62.650 to $63.450, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.